1 Kitahara CM,Sosa JA.The changing incidence of thyroid cancer[J].Nat Rev Endocrinol,2016,12(11):646-653. 2 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. 3 廖安迪,张王峰,胡达堂,等.促甲状腺激素抑制疗法对分化型甲状腺癌患者术后复发率及转移率的影响[J].实用临床医药杂志,2016,20(17):100-102. 4 Monzen S,Mariya Y,Wojcik A,et al.Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients[J].Mol Clin Oncol,2015,3(3):692-698. 5 Cho JS,Park MH,Ryu YJ,et al.The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer[J].Ann Surg Treat Res,2015,88(4):187-192. 6 Zablotska LB,Nadyrov EA,Polyanskaya ON,et al.Risk of thyroid follicular adenoma among children and adolescents in belarus exposed to iodine-131 after the chornobyl accident[J].Am J Epidemiol,2015,182(9):781-790. 7 Charalambous A.Seeking optimal management for radioactive iodine therapy-induced adverse effects[J].Asia Pac J Oncol Nurs,2017,4(4):319-322. 8 Simonovic SZ,Mihaljevic O,Majstorovic I,et al.Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer:elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy[J].Cancer Immunol Immunother,2015,64(1):75-82. 9 罗全勇,陈立波,余永利,等.131I治疗后分化型甲状腺癌患者外周血淋巴细胞亚群的变化[J].中华内分泌代谢杂志,2006,22(1):52-54. 10 范贤东,廖梓宏,王安波.131I治疗后分化型甲状腺癌患者近期外周血中中性粒细胞、淋巴细胞的动态表达[J].标记免疫分析与临床,2016,23(5):505-508. 11 Zhang L,Chen J,Xu C,et al.Effects of iodine-131 radiotherapy on Th17/Tc17 and Treg/Th17 cells of patients with differentiated thyroid carcinoma[J].Genome Integr,2018,15(3):2661-2666. 12 张王峰,叶常青,袁梦晖,等.131碘治疗对甲状腺癌术后患者血象影响的观察[J].人民军医,2010,53(6):424-426. 13 杜锦芳,潘树芳,孙珏,等.基于NK细胞的肿瘤免疫研究进展[J].现代肿瘤医学,2016,24(4):671-675. 14 Oyer JL,Igarashi RY,Kulikowski AR,et al.Generation of highly cytotoxic natural killer cells for treatment of AML using feeder-free particle based approach[J].Biol Blood Marrow Transplant,2015,21(4):632-639. 15 程卫,赵华.重组人促甲状腺激素辅助131I在儿童和青少年分化型甲状腺癌的临床研究[J].实用肿瘤学杂志,2016,30(4):309-313. 16 Emilie M,Charlotte B,Daniel O.When breast cancer cells start to fend the educational process of NK cells off[J].Oncoimmunology,2013,2(12):e26688. 17 Stringaris K,Sekine T,Khoder A,et al.Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia[J].Haematologica,2014,99(5):836-847. 18 Hamivand Z,Haddadi G,Fardid R.Expression of Bax and Bcl2 genes in peripheral blood lymphocytes of patients with differentiated thyroid cancer[J].J Med Phys,2018,43(1):41-45. 19 Vrndic OB,Djurdjevic PM,Jovanovic DD,et al.Blood cells in thyroid cancer patients:a possible influence of apoptosis[J].Open Medicine,2016,11(1):87-92. 20 郑晓东,蒲涛,罗义,等.术前不同剂量碘131治疗对甲状腺癌细胞的杀伤效应及对唾液腺功能的影响[J].海南医学院学报,2015,21(11):1562-1565. 21 李慧,郭宁,张英杰,等.分化型甲状腺癌131I治疗前后外周血细胞的动态变化[J].中华核医学与分子影像杂志,2015,35(2):116-119. 22 Jarzab B,Handkiewicz-Junak D,Wloch J.Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment:a qualitative review[J].Endocr Relat Cancer,2005,12(4):773-803. 23 程峰,文志发,王晓宁,等.模拟核辐射-放射性碘131I照射影响幼鼠免疫系统发育的研究[C].北京:中国免疫学会,2014. 24 Cebulskawasilewska A,Krzysiek M,Krajewska G,et al.Retrospective biological dosimetry at low and high doses of radiation and radioiodine impact on individual susceptibility to ionizing radiation[J].Genome Integr,2017,8:2. 25 Hosseinimehr SJ,Shafaghati N,Hedayati M.Genotoxicity induced by iodine-131 in human cultured lymphocytes[J].Interdiscip Toxicol,2013,6(2):74-76. 26 田文,郗洪庆.甲状腺癌病人生存现状分析[J].中国实用外科学杂志,2016,36(5):489-493. |